Nitto Denko Avecia, a manufacturer of industrial and life-science products, will open a new oligonucleotide active pharmaceutical ingredients manufacturing facility in Milford, Massachusetts. The opening will be in August 2017.

The expansion will add 20,000 square feet of manufacturing and office space at the Milford site to provide cGMP oligonucleotide manufacturing capacity up to 1.8 mol. The total capacity at the Milford site will more than double up to 3.0 mol.

The company has added more than 120 jobs in the last 12 months in Milford and currently has more than 50 open positions at its four locations in Massachusetts, Ohio, and California.  The new positions will specialize in microbiology, analytical chemistry, manufacturing, quality assurance, and engineering.

Source: Nitto Denko Avecia